What adjustments should be made to the treatment regimen for a 15-year-old female patient with type 2 diabetes on Lantus (insulin glargine) 40 units at bedtime and metformin (metformin hydrochloride) 500 mg twice a day, with elevated blood glucose levels and Hemoglobin A1c (HbA1c) of 11.1%?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Adjustments for 15-Year-Old Female with Poorly Controlled Type 2 Diabetes

The current treatment regimen for this adolescent patient with type 2 diabetes should be intensified by increasing the metformin dose to 1000 mg twice daily and adding a rapid-acting insulin before meals, while maintaining the basal insulin glargine (Lantus) at bedtime. 1

Current Status Assessment

  • 15-year-old female with type 2 diabetes
  • Current therapy: Lantus 40 units at bedtime and metformin 500 mg twice daily
  • Non-fasting glucose: 255 mg/dL
  • HbA1c: 11.1% (indicating very poor glycemic control)

Treatment Modifications

Metformin Adjustment

  • Increase metformin from 500 mg twice daily to 1000 mg twice daily 2
  • Titration schedule:
    • Increase by 500 mg weekly to minimize gastrointestinal side effects 1
    • Maximum pediatric dose is 2000 mg daily in divided doses 2
    • Consider extended-release formulation if gastrointestinal intolerance develops 3

Insulin Therapy Intensification

  • Continue Lantus 40 units at bedtime 4
  • Add rapid-acting insulin (lispro, aspart, or glulisine) before meals 1
    • Starting dose: 4 units per meal or 10% of basal insulin dose per meal 1
    • Titrate based on pre-meal and post-meal glucose values 1
    • Target pre-meal glucose: 90-150 mg/dL 1

Rationale for Treatment Approach

  • With HbA1c >9%, more aggressive therapy is required 1
  • For adolescents with significantly elevated HbA1c (>10%), combination therapy with insulin is strongly indicated 1
  • The combination of basal insulin with mealtime insulin is more effective for patients with severe hyperglycemia 1
  • Metformin should be continued as it is the foundation of therapy for type 2 diabetes in adolescents 1

Monitoring and Follow-up

  • Self-monitoring of blood glucose before meals and at bedtime 1
  • Adjust rapid-acting insulin doses based on pre-meal glucose readings 1
  • If pre-meal glucose values are >150 mg/dL in 50% of readings over 2 weeks, increase the dose 1
  • If >2 pre-meal glucose values/week are <90 mg/dL, decrease the dose 1
  • Re-check HbA1c in 3 months 1

Special Considerations for Adolescents

  • Ensure proper education on insulin administration, glucose monitoring, and hypoglycemia management 1
  • Consider potential adherence issues in adolescents 3
  • Emphasize the importance of lifestyle modifications alongside medication adjustments 1
  • Screen for diabetes complications, especially given the high HbA1c level 1

Potential Pitfalls and How to Avoid Them

  • Risk of hypoglycemia with intensified insulin therapy: Start with conservative doses and educate on hypoglycemia recognition and treatment 1
  • Gastrointestinal side effects with increased metformin: Gradual dose titration and taking with meals 1, 2
  • Weight gain with insulin: Continue metformin as it is weight-neutral or promotes modest weight loss 1
  • Adherence challenges: Consider once-daily extended-release metformin if twice-daily dosing is problematic 3
  • Drug interactions: Monitor for medications that may increase hypoglycemia risk when combined with insulin 5

This treatment approach addresses the severe hyperglycemia while providing a structured plan for dose adjustments based on glucose monitoring results, which is essential for achieving target glycemic control in this adolescent patient.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.